Text Size

Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression

This study has been completed.
Sponsor:
Information provided by:
National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:
NCT00090506
First received: August 26, 2004
Last updated: January 23, 2008
Last verified: January 2008
History of Changes

August 26, 2004
January 23, 2008
July 2004
March 2007   (final data collection date for primary outcome measure)
Not Provided
Not Provided
Complete list of historical versions of study NCT00090506 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression
Yoga, Health, and Meditation

The purpose of this study is to plan and develop an international collaboration for research on the health effects of yoga. This study will also determine the effects of yoga on people who are at an increased risk for developing diabetes and people with both HIV and depression.

In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations.

Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.
Interventional
Phase 1
Allocation: Non-Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • HIV Infections
  • Diabetes
  • Depression
Behavioral: Yoga
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
March 2007
March 2007   (final data collection date for primary outcome measure)

Inclusion Criteria for Study 1 Participants:

  • Meet certain laboratory requirements

Inclusion Criteria for Study 2 Participants:

  • HIV infected
  • Able to walk at least 50% of the time

Inclusion Criteria for All Participants:

  • Written informed consent of parent/guardian, if applicable

Exclusion Criteria for Study 2 Participants:

  • Require antiretroviral therapy
Both
14 Years to 40 Years
No
Contact information is only displayed when the study is recruiting subjects
India
 
NCT00090506
R21 AT001942-01
Not Provided
Not Provided
National Center for Complementary and Alternative Medicine (NCCAM)
Not Provided
Principal Investigator: Frederick M. Hecht, MD UCSF Positive Health Program
National Center for Complementary and Alternative Medicine (NCCAM)
January 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP